Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays

作者: Lukas Bubendorf , Peter Schraml , Holger Moch , Pasi Koivisto , Michael J. Mihatsch

DOI:

关键词:

摘要: Prostate cancer development and progression is driven by the accumulation of genetic changes, nature which remains incompletely understood. To facilitate high-throughput analysis molecular events taking place in primary, recurrent, metastatic prostate cancer, we constructed a tissue microarray containing small 0.6-mm cylindrical samples acquired from 371 formalin-fixed blocks, including benign prostatic hyperplasia ( n = 32) primary tumors 223), as well both locally recurrent 54) metastases 62) patients with hormone-refractory disease. Fluorescence situ hybridization (FISH) was applied to consecutive sections probes for five different genes. High-level (≥3X) amplifications were very rare

参考文章(19)
Thomas J. Borell, Michael M. Lieber, David G. Bostwick, James A. Brown, Junqi Qian, Robert B. Jenkins, Satoru Takahashi, Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens American Journal of Pathology. ,vol. 149, pp. 1193- 1199 ,(1996)
Eric J. Kuhn, Richard A. Kurnot, Isabell A. Sesterhenn, Esther H. Chang, Judd W. Moul, Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic Carcinoma Journal of Urology. ,vol. 150, pp. 1427- 1433 ,(1993) , 10.1016/S0022-5347(17)35799-3
Ritva Karhu, Jorma J. Isola, Olli-P. Kallioniemi, Anne H. Kallioniemi, Eija R. Hyytinen, Teuvo Tammela, Tapio Visakorpi, Ann-Christine Syvänen, Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization Cancer Research. ,vol. 55, pp. 342- 347 ,(1995)
Michael M. Lieber, David G. Bostwick, Junqi Qian, Robert B. Jenkins, Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Research. ,vol. 57, pp. 524- 531 ,(1997)
Michael L. Cher, Michael L. Cher, William B. Isaacs, G. Steven Bova, Sokhom S. Pin, Dan H. Moore, Peter R. Carroll, Eric J. Small, Jonathan I. Epstein, Ronald H. Jensen, Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping Cancer Research. ,vol. 56, pp. 3091- 3102 ,(1996)
Alain Latil, Jean-Christophe Baron, Olivier Cussenot, Georges Fournier, Laurent Boccon-Gibod, Alain Le Duc, Rosette Lidereau, Oncogene amplifications in early‐stage human prostate carcinomas International Journal of Cancer. ,vol. 59, pp. 637- 638 ,(1994) , 10.1002/IJC.2910590510
Jeffrey S. Ross, Christine E. Sheehan, Alida M. Hayner-Buchan, Robert A. Ambros, Bhaskar V.�S. Kallakury, Ronald P. Kaufman, Hugh A.�G. Fisher, Matthew D. Rifkin, Patrick J. Muraca, Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma. Cancer. ,vol. 79, pp. 2162- 2170 ,(1997) , 10.1002/(SICI)1097-0142(19970601)79:11<2162::AID-CNCR14>3.0.CO;2-U
G. Fournier, A. Latil, Y. Amet, J. H. Abalain, A. Volant, P. Mangin, H. H. Floch, R. Lidereau, Gene amplifications in advanced-stage human prostate cancer Urological Research. ,vol. 22, pp. 343- 347 ,(1995) , 10.1007/BF00296872
Tapio Visakorpi, Eija Hyytinen, Pasi Koivisto, Minna Tanner, Riitta Keinänen, Christian Palmberg, Aarno Palotie, Teuvo Tammela, Jorma Isola, Olli-P. Kallioniemi, In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genetics. ,vol. 9, pp. 401- 406 ,(1995) , 10.1038/NG0495-401